OneOme’s primary product offering is the RightMed® comprehensive test, a pharmacogenomic test designed to help providers make more informed, evidence-based prescription decisions and avoid medication trial and error. With the RightMed test, providers, pharmacists, and clinical support staff get access to the RightMed Advisor (an online, interactive tool which gives providers additional insights into their patients’ results), several types of reports, and consultations with OneOme’s clinical team.
OneOme also offers its RightMed clinical decision support tool for Electronic Medical Record (EMR) integration, as well as single gene tests and custom pharmacogenomic services.
The RightMed comprehensive test is a pharmacogenomic test that analyzes a patient’s DNA to determine how he or she may respond to certain medications. The test covers hundreds of medications for a wide range of medical conditions, including cancer, psychiatric conditions, chronic pain, cardiovascular disease, and more. It analyzes a large set of genes that have been shown, based on OneOme’s rigorous research* and standards for inclusion, to affect how a patient metabolizes many commonly prescribed medications.
With the RightMed test, providers, pharmacists, and clinical support staff get access to the RightMed Advisor, RightMed reports, and a clinical decision support tool that is available as an add-on:
The RightMed Advisor is an interactive tool that helps make pharmacogenomic test results clinically actionable. With the RightMed Advisor, providers, pharmacists, and clinical support staff can quickly and easily interpret test results, access OneOme’s expertly curated pharmacogenomic database, view pharmacogenomic clinical guidelines, evaluate drug-to-drug interactions, explore alternative medications, generate custom reports, and more.
When providers order the RightMed test, they receive the comprehensive test report, which includes their patients’ pharmacogenomic results for all medications covered by the test. In addition to this report, providers get access to several other types of reports. These include the RightMed Advisor custom reports, which are customized by the provider to include medications that are most relevant to the patient, as well as RightMed specialty reports, which contain a subset of medications most relevant for a specific medical specialty.
Available as an add-on to the RightMed test is OneOme’s cloud-hosted platform that integrates test results into Electronic Medical Records (EMRs). The tool provides real-time, clinically actionable prescription decision support.
If you are interested in learning more about this tool and pricing options, please CONTACT US.
Providers can place an order for a specific, single gene. Unlike the RightMed comprehensive test, the single gene test results are provided in an analytical report only, and do not include medication classification or clinical guidelines.
Single gene tests are currently available for:
NOTE: All single genes are included with the RightMed comprehensive test except for MTHFR. While MTHFR is not automatically included with a RightMed test order, it is available as an optional and complimentary add-on.
OneOme can work closely with organizations to implement custom services, including:
Customers can submit genotype or next-generation sequence (NGS) data to OneOme and receive our pharmacogenomic report in return. This interpretative report is the same as the report provided with the RightMed comprehensive test, but it is based on data collected outside of OneOme's laboratory.
OneOme’s CAP/CLIA certified laboratory offers custom services, including specialized gene panels, custom genotyping, single gene testing, and confirmation/validation testing services.
If you are interested in learning more about these custom services, please CONTACT US.
If you are a patient, you can learn more about the RightMed test and how to get it by downloading our PATIENT TOOLKIT.